Alexander V. Lazarev
Net Worth
Last updated:
What is Alexander V. Lazarev net worth?
The estimated net worth of Dr. Alexander V. Lazarev is at least $3,428,003 as of 14 Sep 2021. He owns shares worth $3 as insider and has received compensation worth at least $3,428,000 in Pressure BioSciences, Inc..
What is the salary of Alexander V. Lazarev?
Dr. Alexander V. Lazarev salary is $214,250 per year as Chief Science Officer in Pressure BioSciences, Inc..
How old is Alexander V. Lazarev?
Dr. Alexander V. Lazarev is 60 years old, born in 1965.
What stocks does Alexander V. Lazarev currently own?
As insider, Dr. Alexander V. Lazarev owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pressure BioSciences, Inc. (PBIO) | Chief Science Officer | 26,460 | $0 | $3 |
What does Pressure BioSciences, Inc. do?
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.
Alexander V. Lazarev insider trading
Pressure BioSciences, Inc.
Pressure BioSciences key executives
Pressure BioSciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Alexander V. Lazarev (60) Chief Science Officer
- Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. (70) Senior Vice President of Engineering
- Mr. Richard T. Schumacher (75) Founder, Pres, Chief Executive Officer, Treasurer, Interim Chief Financial Officer, Clerk & Director